{"id":40830,"date":"2022-03-01T07:10:39","date_gmt":"2022-03-01T07:10:39","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=40830"},"modified":"2022-09-12T07:56:03","modified_gmt":"2022-09-12T07:56:03","slug":"resources-on-long-covid","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/40830","title":{"rendered":"Resources on Long COVID"},"content":{"rendered":"
\n

<\/span>Simon Collins, HIV i-Base<\/strong><\/p>\n

Many of the following links were included in previous issues of HTB.\u00a0<\/span>Other related resources are added below.<\/strong><\/p>\n

Symptoms and risk factors for long COVID in non-hospitalized adults.<\/strong> Subramanian A et al.\u00a0Nat Med (2022). doi: 10.1038\/s41591-022-01909-w.
\nhttps:\/\/www.nature.com\/articles\/s41591-022-01909-w<\/a>
\nLarge retrospective matched cohort study using a UK-based primary care database with roughly 500,000 cases and 2 million controls.<\/p>\n<\/div>\n

\n

Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study,<\/strong> Huang L et al. Lancet Respiratory Medicine. DOI:10.1016\/S2213-2600(22)00126-6. (11 May 2022).
\nhttps:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(22)00126-6\/fulltext<\/a>
\nThis paper reports that 55% of people still have one related symptom more than two years after COVID-19.<\/p>\n

UK Independent SAGE webinar on Long COVID<\/strong> (17 June 2022).
\nhttps:\/\/www.youtube.com\/watch?v=g60waH14oZg<\/a><\/p>\n

MMWR review estimates 1 in 5 people have at least one symptoms that qualifies as long COVID.
\n<\/strong>Bull-Otterson L et al. Post\u2013COVID Conditions Among Adult COVID-19 Survivors Aged 18\u201364 and \u226565 Years \u2014 United States, March 2020\u2013November 2021. MMWR Morb Mortal Wkly Rep 2022;71:713\u2013717.
\nhttp:\/\/dx.doi.org\/10.15585\/mmwr.mm7121e1<\/a>.<\/p>\n

Upcoming virtual workshop:<\/strong>
\nLong-Term Health Effects from COVID-19 and Implications<\/p>\n

Monday, March 21, 2022 – 10:30am – 4:00pm US Eastern time
\nTuesday, March 22, 2022 – 10:30am – 3:30pm US Eastern time<\/p>\n

The National Academies will hold a public workshop to explore the long-term and potentially disabling health effects stemming from COVID-19 infection and how they might impact survivors\u2019 ability to work.
\nFree registration.<\/a><\/p>\n

Long COVID may be more common in people living with HIV
\n<\/strong>HTB review of small US study (Peluso et al, see below).
\nhttps:\/\/i-base.info\/htb\/42389<\/a>
\n<\/strong><\/p>\n

Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection.<\/strong> Peluso MJ et al. Preprint. medRxIV. (14 February 2022).
\nhttps:\/\/www.medrxiv.org\/content\/10.1101\/2022.02.10.22270471v1.full<\/a><\/p>\n<\/div>\n

\n

Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.<\/strong> Lund LC et al.\u00a0Lancet Infect Dis.2021. (Oct 2021).
\nhttps:\/\/doi.org\/10.1016\/S1473-3099(21)00211-5<\/a><\/p>\n

Outcomes at 6- and 12-months in >1200 adults with COVID-19 in Wuhan, China. <\/strong>Approximately 50% reported at least one complication sustained to 12 months.
\nRef: Huang L et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet.\u00a0DOI:\u00a010.1016\/S0140-6736(21)01755-4 (28 August 2021).<\/p>\n

Lancet editorial. DOI: DOI:\u00a010.1016\/S0140-6736(21)01900-0.\u00a0(28 August 2021).<\/strong>
\nhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)01900-0\/fulltext<\/a><\/p>\n<\/div>\n

\n

The HIV Movement Must Come Through<\/span><\/strong>
\nJD Davids in POZ magazine. (June 2021)
\nhttps:\/\/www.poz.com\/article\/hiv-movement-must-come-through<\/a>
\n<\/span><\/p>\n<\/div>\n

\n

Long-time HIV activist JD Davids, writes about approaches to managing Long COVID through their experience of living with myalgic encephalomyelitis (ME) and lessons from HIV activism. Also includes a resources section.<\/span><\/p>\n

\n

See also online seminars from August 2020 that include many other community presentations.
\n<\/span>https:\/\/www.meaction.net\/longcovid<\/a><\/p>\n<\/div>\n<\/div>\n

\n

Long COVID website
\n<\/span><\/b>https:\/\/www.longcovid.org<\/a><\/p>\n

One of the early and leading community websites<\/p>\n<\/div>\n

\n

Body Politic website
\n<\/span><\/b>https:\/\/www.wearebodypolitic.com\/covid19<\/a><\/p>\n<\/div>\n

\n

Another early peer-led community website.<\/p>\n<\/div>\n

Webcasts of two-day US Workshop on Long COVID (PASC) now online
\n<\/span><\/b>HTB (22 January 2021).
\nhttps:\/\/i-base.info\/htb\/39624<\/a><\/p>\n

\n

HTB report on meeting and webcasts from an important 2-day NIH workshop on Long COVID with online links.<\/span><\/p>\n<\/div>\n

\n

NIHR. Living with COVID-19.<\/span><\/b>
\n<\/span>https:\/\/evidence.nihr.ac.uk\/themedreview\/living-with-covid19<\/a><\/p>\n<\/div>\n

A 29-page NIHR review also looks a personal experiences of COVID-19 including the increasing reports of long-term symptoms and how to manage them.<\/span><\/div>\n
\n

NICE issue UK guidelines on long COVID
\n<\/span><\/b>HTB (22 January 2021).
\nhttps:\/\/i-base.info\/htb\/39597<\/a><\/p>\n<\/div>\n

\n

Summary of UK guidelines for health workers managing Long COVID.<\/span><\/p>\n

\n
\n

Long COVID: studies reporting on long-term follow up on COVID-19.
\n<\/span><\/b>HTB (3 March 2021).
\nhttps:\/\/i-base.info\/htb\/40575<\/a>
\nReview of five studies reporting duration of post-COVID that includes new symptoms after COVID was thought to have finished.<\/p>\n<\/div>\n

Long COVID: Mild infection and sustained long-term complications.
\n<\/span><\/b>HTB (20 October 2020).
\nhttps:\/\/i-base.info\/htb\/39126<\/a><\/p>\n<\/div>\n<\/div>\n

\n

Pathogenesis and treatment of COVID-19 including Long COVID
\n<\/span><\/b>HTB (14 October 2020).
\nhttps:\/\/i-base.info\/htb\/39054<\/a><\/p>\n<\/div>\n

\n

HTB report of an excellent talk by Professor Karine Lacombe from the Glasgow HIV Congress.<\/span><\/p>\n<\/div>\n

\n
\n

Management of post-acute covid-19 in primary care.
\n<\/span><\/b>BMJ 2020; 370 doi:10.1136\/bmj.m3026. (11 August 2020).
\nhttps:\/\/www.bmj.com\/content\/370\/bmj.m3026<\/a>
\nA BMJ podcast on post-acute and chronic COVID-19 to support management in primary care.<\/p>\n<\/div>\n

\n

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.
\n<\/span><\/b>Davis HE et al. Pre-review draft. MedRxiv. DOI: 10.1101\/2020.12.24.20248802. (5 April 2021). https:\/\/www.medrxiv.org\/content\/10.1101\/2020.12.24.20248802v3<\/a>
\nAn early community survey published as a pre-review paper that included approximately 4000 people self-reporting symptoms.<\/p>\n<\/div>\n

\n

Recovery from severe COVID-19: leveraging the lessons of survival from sepsis.
\n<\/span><\/b>Prescott HC et al. JAMA. 2020;324(8):739-740. DOI:10.1001\/jama.2020.14103. (5 August 2020).
\nhttps:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2769290<\/a>
\nA useful article on recovery from severe COVID-19 in JAMA.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Simon Collins, HIV i-Base Many of the following links were included in previous issues of HTB.\u00a0Other related resources are added below. Symptoms and risk factors for long COVID in non-hospitalized adults. Subramanian A et al.\u00a0Nat Med (2022). doi: 10.1038\/s41591-022-01909-w. https:\/\/www.nature.com\/articles\/s41591-022-01909-w …<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[311,287,278],"tags":[],"class_list":["post-40830","post","type-post","status-publish","format-standard","hentry","category-long-covid","category-covid-19-on-the-web","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=40830"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/40830\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=40830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=40830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=40830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}